Product Main Parameters

Common Product Specifications

Product Manufacturing Process

The sFlT-1/PlGF test is produced following strict guidelines, ensuring high quality and reliability. Diagnostic testing advancements emphasize the necessity of sensitive assays, which are achieved through recombinant protein technology and monoclonal antibody development. Such technologies facilitate accurate detection and quantification of the sFlT-1 and PlGF markers, critical for assessing pre-eclampsia risk. According to recent studies, the integration of these biotechnological advancements permits the creation of robust diagnostic tools that are crucial for modern obstetrics, enhancing patient outcomes significantly.

Product Application Scenarios

The sFlT-1/PlGF Test is used in clinical settings to evaluate pregnant women suspected of developing pre-eclampsia, a condition that poses significant risks if not identified early. Research highlights its utility in stratifying risk levels and guiding timely interventions, potentially reducing health complications. Hospitals and specialized clinics benefit from incorporating this test into prenatal care, as it aids in early diagnosis and patient management, ultimately contributing to safer pregnancies and childbirth by preemptively addressing hypertensive disorders.

Product After-Sales Service

We offer comprehensive after-sales support for our wholesale customers, including training manuals, online resources, and customer service assistance for technical issues. Replacement or refund options are available for defective products.

Product Transportation

All sFlT-1/PlGF test kits are carefully packed and transported under controlled conditions to prevent damage or contamination, ensuring they arrive in optimal condition for use.

Product Advantages

• High predictive value with non-invasive procedure
• Facilitates early intervention and risk management
• Simple and quick to administer
• Scalable for large healthcare facilities

Product FAQ

• Q1: What is the sFlT-1/PlGF Test used for?
  A1: The sFlT-1/PlGF Test is designed for the detection of pre-eclampsia in pregnant women, providing a non-invasive and reliable method to assess risk levels early.
• Q2: How is this test administered?
  A2: This test is performed by collecting a blood sample, which is then processed to measure the levels of sFlT-1 and PlGF.
• Q3: What are the benefits of using this test?
  A3: The test enables early detection of pre-eclampsia, allowing for timely interventions, which can improve outcomes for both the mother and the fetus.
• Q4: Can this test be used at any time during pregnancy?
  A4: Yes, the test is applicable especially after the 20th week of gestation, a period when pre-eclampsia typically develops.
• Q5: Are there any known limitations of the test?
  A5: Yes, while highly effective, the test is not universally available and may be cost-prohibitive for some healthcare providers.
• Q6: Is the test result immediate?
  A6: Results are generally available within 15 minutes, making it a quick diagnostic tool in clinical settings.
• Q7: How accurate is the sFlT-1/PlGF Test?
  A7: The test is highly sensitive, providing reliable results that can accurately identify women at risk of developing pre-eclampsia.
• Q8: What should be done if the test result is positive?
  A8: A positive test result warrants further evaluation and monitoring by a healthcare professional to implement appropriate management strategies.
• Q9: Is this test safe?
  A9: Yes, as a non-invasive blood test, it poses minimal risk to both mother and fetus.
• Q10: How should the test be stored?
  A10: The test kits should be stored at temperatures between 2 and 30°C and should not be frozen.

Product Hot Topics

• Importance of Early Detection in Pre-eclampsia:
  Current studies underscore the importance of early detection in managing pre-eclampsia. The sFlT-1/PlGF Test, offered wholesale, offers a reliable diagnostic tool that helps healthcare providers identify the condition before it progresses to severe complications. This proactive approach not only saves lives but also empowers clinicians with timely data to make informed decisions regarding patient care.
• The Evolution of Diagnostic Tools in Obstetrics:
  The wholesale availability of the sFlT-1/PlGF Test is a testament to the evolving landscape of diagnostic tools in obstetrics. By providing rapid, accurate testing, it allows for better management of high-risk pregnancies. This evolution is driven by the demand for safer, more effective diagnostic solutions that support positive health outcomes for mothers and their babies, a cornerstone of modern healthcare practices.

Image Description